Study Stopped
IRB closed
Diagnosis of ON With or Without MS or NMOSD
Utility of Quantification of Afferent Pupillary Defect in Predicting Optic Nerve Disease in Retrobulbar Neuritis, Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease - a Retrospective and Prospective Analysis
1 other identifier
observational
112
1 country
1
Brief Summary
This is both a prospective and retrospective study of patients with a known diagnosis of optic neuritis (ON) only, multiple sclerosis (MS) with ON, or neuromyelitis spectrum disorder (NMOSD) with ON. There will be no requirement for blinding (patient or assessor) and data collected with the Reflex app will be compared against other data that track optic nerve functional status, such as optical coherence tomography (OCT), visual fields (VF), low-contrast sensitivity, MRI orbits/brain and visual evoked potentials (VEP). Patients who have any diagnosis of ON, with or without a diagnosis of MS or NMOSD and who have had testing using other modalities such as VEPs, VF, low-contrast sensitivity studies, OCT, and MRI of brain or orbits will be included as retrospective subjects in the study. In this cohort, RAPD assessments will be completed and compared to against the data that has accrued as noted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 4, 2019
CompletedFirst Submitted
Initial submission to the registry
October 17, 2019
CompletedFirst Posted
Study publicly available on registry
October 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 6, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 6, 2022
CompletedNovember 14, 2022
November 1, 2022
2.9 years
October 17, 2019
November 9, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Feasibility of device for diagnosis of ON
Feasibility of using quantified pupillary responses as a surrogate marker for assessment of optic nerve dysfunction in ON, MS, and NMOSD.
10 seconds
Comparative data assessment
Comparing Reflex with other routine clinical methods of evaluating optic nerve dysfunction
Time of app scan (10s) plus time to compare data (1-2 hours)
Study Arms (3)
Optic neuritis diagnosis only
Patients who have a diagnosis of optic neuritis, without a diagnosis of MS or NMOSD.
ON and multiple sclerosis
Patients who have a diagnosis of optic neuritis AND multiple sclerosis.
ON and NMOSD
Patients who have a diagnosis of optic neuritis and neuromyelitis optica spectrum disorder.
Interventions
The Reflex pupillometer is a mobile based application that provides a quantitative way to monitor pupillary activity and responsiveness. It uses the mobile phone as a source of light and records pupillary response, as well as analyzes and compiles the data. It produces quantitative measures such as latency, minimum and maximum pupil diameter, maximum and average constriction velocity, dilation velocity, and 75% recovery time.
Eligibility Criteria
Eligible patients include those seen at the University of Kentucky during routine clinical neurology visits between the ages of 18 and 90 years who have been diagnosed with optic neuritis, optic neuritis and multiple sclerosis, or optic neuritis and neuromyelitis optica spectrum disorder and have had at least one previous test that tracks optic nerve function.
You may qualify if:
- Male or female patients ages 18-90 years
- Signed informed consent
- Have been diagnosed with optic neuritis (ON) only, MS and ON, or NMOSD and ON
- Have had at least one previous test to track optical nerve function
You may not qualify if:
- Are pregnant or nursing
- Are children (age \<18 years)
- Do not have a diagnosis of optic neuritis (ON)
- Have a diagnosis of MS or NMOSD without a diagnosis of ON as well
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Kentucky
Lexington, Kentucky, 40536, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jagannadha Avasarala, MD PhD
University of Kentucky
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor of Neurology
Study Record Dates
First Submitted
October 17, 2019
First Posted
October 18, 2019
Study Start
October 4, 2019
Primary Completion
September 6, 2022
Study Completion
September 6, 2022
Last Updated
November 14, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share